Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Microbiological Molecular Assay Analyses Heart Valve Tissue

By LabMedica International staff writers
Posted on 05 Feb 2013
Positive heart valve (HV) culture is a major criterion for the diagnosis of infective endocarditis, but is poorly sensitive compared with molecular assays. More...


Molecular methods applied directly to HV tissue have shown promise in negative-culture infective endocarditis and sequencing of the gene encoding 16S ribosomal ribonucleic acid (rRNA) is an accurate means of identifying microorganisms and, offers sensitive and rapid diagnosis.

Scientists at the Central University Hospital at Limoges (CHU; France) applied a two-step broad-range polymerase chain reaction (PCR) and a specific real-time PCR to HV samples and compared the results with those of serologic tests and conventional microbiological methods. This study examined HV samples excised from 31 patients with definite endocarditis based on Duke's modified criteria, between January 1, 2002, and December 31, 2007. The aortic valve was affected in 15 cases and the mitral valve in 16 cases.

Two broad-range PCR methods were applied to the 31 HV samples. The first was a real-time (RT-PCR) method, followed by a conventional end-point PCR that was applied to HV samples on which the first PCR was negative. Five specific RT-PCR procedures were also used in order to identify Bartonella spp., Tropheryma whipplei, Chlamydophila pneumoniae, Mycoplasma pneumonia, and Coxiella burnetii. Blood cultures were positive in 23 cases.

The RT-PCR was positive in 11 of the 23 patients with blood culture-positive endocarditis. All the sequencing results matched the blood culture results to the genus level at least. Seven culture-negative HV specimens gave an amplification product, sequencing of which identified Streptococcus mutans in one patient and Streptococcus anginosus in another patient. Streptococcus gallolyticus was found three patients and Staphylococcus epidermidis in two patients. Specific PCR identified one T. whipplei, which was also identified by conventional end-point PCR.

The authors concluded that the strategy of combining the two-step broad-range PCR methods improved the sensitivity of the molecular method from 38.7% to 58%. Their results confirm that blood culture is still the gold standard for the diagnosis of infective endocarditis, but does show that molecular methods applied to HV can be useful when blood culture is negative. The study was published January 12, 2013, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Central University Hospital at Limoges



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.